Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial
Authors:
- 2 January 2021
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 74 (1) , 141-148
Abstract
Non-supplemental carotenoids and retinol may potentiate antioxidant and anti-inflammatory mechanisms. Chronic intraprostatic inflammation is linked to prostate carcinogenesis. We investigated the association of circulating carotenoids and retinol with intraprostatic inflammation in benign tissue. We included 235 men from the Prostate Cancer Prevention Trial placebo arm who had a negative end-of-study biopsy, most (92.8%) done without clinical indication. alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and retinol were assessed by high-performance liquid chromatography using pooled year 1 and 4 serum. Presence and extent of intraprostatic inflammation in benign tissue was assessed in 3 (of 6-10) biopsy cores. Logistic (any core with inflammation vs none) and polytomous logistic (some or all cores with inflammation vs none) regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) of intraprostatic inflammation by concentration tertile adjusting for age, race, prostate cancer family history, and serum cholesterol. None of the carotenoids or retinol was associated with intraprostatic inflammation, except beta-cryptoxanthin, which appeared to be positively associated with any core with inflammation [vs none, T2: OR (95% CI) = 2.67 (1.19, 5.99); T3: 1.80 (0.84, 3.82), P-trend = 0.12]. These findings suggest that common circulating carotenoids and retinol are not useful dietary intervention targets for preventing prostate cancer via modulating intraprostatic inflammation.Keywords
This publication has 38 references indexed in Scilit:
- Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US menCancer Causes & Control, 2011
- Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialCancer Epidemiology, Biomarkers & Prevention, 2011
- Serum Retinol and Risk of Prostate CancerAmerican Journal of Epidemiology, 2011
- Retinoids, Retinoic Acid Receptors, and CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial ExperienceCancer Prevention Research, 2010
- Serum Retinol and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCancer Epidemiology, Biomarkers & Prevention, 2009
- Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F2t in serum or urine with prostate cancer risk: the multiethnic cohortCancer Causes & Control, 2009
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy TrialJNCI: Journal of the National Cancer Institute, 1996
- Relation of Serum Vitamins a and E and Carotenoids to the Risk of CancerNew England Journal of Medicine, 1984